SCHEMBL22459360

SCHEMBL22459360

C=CC(=O)OCCOc1ccc(-c2ccc(OCCOC(=O)C(=C)COC)cc2CC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 2/20 0.44
▸ SRD5A2 P31213 1/20 0.39
▸ CHEK2 O96017 1/20 0.35
▸ TSHR P16473 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ FFAR1 O14842 4/20 0.33
▸ FFAR4 Q5NUL3 4/20 0.33
▸ PPARG P37231 2/20 0.33
▸ PTPN11 Q06124 2/20 0.33
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA2 P54646 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAG3 Q9UGI9 1/20 0.32
▸ PRKAG2 Q9UGJ0 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ ACACB O00763 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459251 0.93 THRB (0.38) THRBSRD5A2TSHRHPGDMAPK1
SCHEMBL22459823 0.88 THRB (0.44) THRBCHEK2HPGDMAPK1HSD17B10
SCHEMBL22459556 0.88 SRD5A2 (0.42) SRD5A2CHEK2TSHRHPGDMAPK1
SCHEMBL22459389 0.87 SRD5A2 (0.39) SRD5A2CHEK2TSHRMAPK1RECQL
SCHEMBL22459560 0.85 THRB (0.44) THRBCHEK2TSHRHSD17B10FFAR1
SCHEMBL22459258 0.85 PPARG (0.41) SRD5A2TSHRMAPK1RECQLHSD17B10
SCHEMBL22459362 0.82 THRB (0.37) THRBCHEK2MAPK1HSD17B10TDP1
SCHEMBL22459790 0.82 THRB (0.47) THRBCHEK2ACACBACACATDP1
SCHEMBL22459349 0.81 THRB (0.47) THRBTSHRHPGDFFAR1PPARG
SCHEMBL22459248 0.79 POLB (0.43) THRBCHEK2PPARGACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 THRB 4816/4885SRD5A2 1354/4885CHEK2 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback